2051 - 2060 of 6284 Results
Title
Year
- Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study2021OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 23
- Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia2021OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 11
- Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis2021OPENTitle: Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database AnalysisJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 435End Page: 448Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00309-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00309-5.pdfCitation Count: 12
- Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia2021OPENTitle: Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 307End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00246-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00246-3.pdfCitation Count: 13
- MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain2021OPENTitle: MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse BrainJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2529End Page: 2540Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01130-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01130-6.pdfCitation Count: 20
- Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omics2021OPENTitle: Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omicsJournal Name: Particle and Fibre ToxicologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12989-021-00433-yBest OA location URL: https://particleandfibretoxicology.biomedcentral.com/track/pdf/10.1186/s12989-021-00433-yCitation Count: 18
- Factors associated with impaired quality of life three months after being diagnosed with COVID-192021OPENTitle: Factors associated with impaired quality of life three months after being diagnosed with COVID-19Journal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 5Start Page: 1401End Page: 1414Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11136-021-02998-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11136-021-02998-9.pdfCitation Count: 35
- Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages2021OPENTitle: Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stagesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88877-2Best OA location URL: https://www.nature.com/articles/s41598-021-88877-2.pdfCitation Count: 26
-
OPENTitle: Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cellsJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 9Start Page: 850End Page: 863Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00110-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8728893Citation Count: 35
-
OPENTitle: Activation mechanism of PINK1Journal Name: NaturePublisher: Springer Science and Business Media LLCVol: 602Issue #: 7896Start Page: 328End Page: 335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-021-04340-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8828467Citation Count: 88